Awareness of Rheumatic Heart Disease in Egypt: A National Multicenter Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Participants
2.3. Data Collection Tool
2.4. Statistical Analysis
2.5. Ethical Considerations
3. Results
3.1. Demographics
3.2. Exposure
3.3. Medication Use
3.4. Knowledge on the Association between Sore Throat and RHD
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Collaborators
Abbreviations
ARF | Acute rheumatic fever |
GAS | Group A streptococci |
RHD | Rheumatic heart disease |
References
- Carapetis, J.R.; Beaton, A.; Cunningham, M.W.; Guilherme, L.; Karthikeyan, G.; Mayosi, B.M.; Sable, C.; Steer, A.; Wilson, N.; Wyber, R.; et al. Acute rheumatic fever and rheumatic heart disease. Nat. Rev. Dis. Primers 2016, 2, 1–24. [Google Scholar] [CrossRef] [Green Version]
- Zühlke, L.J.L.; Beaton, A.A.; Engel, M.M.; Hugo-Hamman, C.C.; Karthikeyan, G.; Katzenellenbogen, J.; Ntusi, N.N.; Ralph, A.A.; Saxena, A.A.; Smeesters, P.R.; et al. Group A streptococcus, acute rheumatic fever and rheumatic heart disease: Epidemiology and clinical considerations. Curr. Treat. Options Cardiovasc. Med. 2017, 19, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murray, C.J.L.; Barber, R.M.; Foreman, K.J.; Ozgoren, A.A.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; Abraham, J.P.; Abubakar, I.; Abu-Raddad, L.J.; et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: Quantifying the epidemiological transition. Lancet 2015, 386, 2145–2191. [Google Scholar] [CrossRef] [Green Version]
- Marijon, E.; Mirabel, M.; Celermajer, D.S.; Jouven, X. Rheumatic heart disease. Lancet 2012, 379, 953–964. [Google Scholar] [CrossRef]
- Zühlke, L.J.; Steer, A.C. Estimates of the global burden of rheumatic heart disease. Glob. Heart 2013, 8, 189–195. [Google Scholar] [CrossRef] [Green Version]
- Vos, T.; Lim, S.S.; Abbafati, C.; Abbas, K.M.; Abbasi, M.; Abbasifard., M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; Abdollahi, M.; et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020, 396, 1204–1222. [Google Scholar] [CrossRef]
- Egyptian Ministry of Health and Population. National RHD prevention and control Program. PLoS Negl. Trop. Dis. 2018, 14, e0008558. [Google Scholar]
- Ghamrawy, A.; Ibrahim, N.N.; Abd El-Wahab, E.W. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006–2018). PLoS Negl. Trop. Dis. 2020, 14, e0008558. [Google Scholar] [CrossRef] [PubMed]
- Abul-Fadl, A.M.A.M.; Mourad, M.M.; Ghamrawy, A.; Sarhan, A.E. Trends in deaths from rheumatic heart disease in the eastern mediterranean region: Burden and challenges. J. Cardiovasc. Dev. Dis. 2018, 5, 32. [Google Scholar] [CrossRef] [Green Version]
- Kotit, S.; Said, K.; ElFaramawy, A.; Mahmoud, H.; Phillips, D.I.W.; Yacoub, M.H. Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease. Open Heart 2017, 4, e000702. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Engel, M.E.; Zuhlke, L.; Robertson, K. Rheumatic fever and rheumatic heart disease: Where are we now in South Africa?: ASAP programme. SA Heart 2009, 6, 20–23. [Google Scholar]
- Sanyahumbi, A.S.; Sable, C.A.; Beaton, A.; Chimalizeni, Y.; Guffey, D.; Hosseinipour, M.; Karlsten, M.; Kazembe, P.N.; Kennedy, N.; Minard, C.G.; et al. School and community screening shows Malawi, Africa, to have a high prevalence of latent rheumatic heart disease. Congenit. Heart Dis. 2016, 11, 615–621. [Google Scholar] [CrossRef]
- Lozano, R.; Fullman, N.; Mumford, J.E.; Knight, M.; Barthelemy, C.M.; Abbafati, C. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: A systematic analysis for the global burden of disease study 2019. Lancet 2020, 396, 1250–1284. [Google Scholar] [CrossRef]
- Nordet, P.; Lopez, R.; Duenas, A.; Sarmiento, L. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996-2002). Cardiovasc. J. Afr. 2008, 19, 135–140. [Google Scholar] [PubMed]
- Ramsey, L.S.; Watkins, L.; Engel, M.E. Health education interventions to raise awareness of rheumatic fever: A systematic review protocol. Syst. Rev. 2013, 2, 1–4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nkoke, C.; Luchuo, E.B.; Jingi, A.M.; Makoge, C.; Hamadou, B.; Dzudie, A. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting. PLoS ONE 2018, 13, e0203864. [Google Scholar] [CrossRef] [PubMed]
- Wickham, H.; François, R.; Lionel Henry, K.M. dplyr: A Grammar of Data Manipulation R package version 1.0.2. 2020. [Google Scholar]
- Wickham, H. tidyr: Tidy Messy Data. R package version 1.1.2. 2020. [Google Scholar]
- Harrell, F.E. rms: Regression Modeling Strategies. R package version 6.2-0. 2021. [Google Scholar]
- Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020, 76, 2982–3021. [Google Scholar] [CrossRef] [PubMed]
- Watkins, D.A.; Johnson, C.O.; Colquhoun, S.M.; Karthikeyan, G.; Beaton, A.; Bukhman, G. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N. Engl. J. Med. 2017, 377, 713–722. [Google Scholar] [CrossRef]
- Saeed, M.H.; Afzal, M.S. Awareness of rheumatic heart disease in patients suffering from rheumatic heart disease. J. Univ. Med. Dent. Coll. 2016, 7, 64–70. [Google Scholar]
- Bergmark, R.; Bergmark, B.; Blander, J.; Fataki, M.; Janabi, M. Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania. Pediatr. Infect Dis. J. 2010, 29, 1135–1137. [Google Scholar] [CrossRef]
- Gurney, J.K.; Chong, A.; Culliford-Semmens, N.; Tilton, E.; Wilson, N.J.; Sarfati, D. High levels of rheumatic fever and sore throat awareness among a highrisk population screened for rheumatic heart disease. N. Z. Med. J. 2017, 130, 107–110. [Google Scholar] [PubMed]
- Arya, R.K. Awareness about sore-throat, rheumatic fever and rheumatic heart disease in a rural community. Indian J. Public Health 1992, 36, 63–67. [Google Scholar]
- Bach, J.; Chalons, S.; Mosser, A.; Forier, E.; Elana, G.; Jouanelle, J.; Kayemba, S.; Delbois, D.; Sainte-Aimé, C.; Berchel, C. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996, 347, 644–648. [Google Scholar] [CrossRef]
- Osman, G.M.; Abdelrahman, S.M.K.; Ali, S.K.M. Evaluation of physicians’ knowledge about prevention of rheumatic fever and rheumatic heart disease before and after a teaching session. Sudan J. Paediatr. 2015, 15, 37. [Google Scholar]
- Mayosi, B.M. The four pillars of rheumatic heart disease control. SAMJ S. Afr. Med. J. 2010, 100, 506. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zuhlke, L.; Engel, M.; Karthikeyan, G.; Rangarajan, S.; Mackie, P.; Cupido, B.; Mauff, K.; Islam, S.; Joachim, A.; Daniels, R.; et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur. Heart J. 2015, 36, 1115–1122. [Google Scholar] [CrossRef] [Green Version]
- Sortsø, C.; Lauridsen, J.; Emneus, M.; Green, A.; Jensen, P.B. Socioeconomic inequality of diabetes patients’ health care utilization in Denmark. Health Econ. Rev. 2017, 7, 21. [Google Scholar] [CrossRef] [Green Version]
- Jansen, T.; Rademakers, J.; Waverijn, G.; Verheij, R.; Osborne, R.; Heijmans, M. The role of health literacy in explaining the association between educational attainment and the use of out-of-hours primary care services in chronically ill people: A survey study. BMC Health Serv. Res. 2018, 18, 1–13. [Google Scholar] [CrossRef]
- Ladwig, K.; Marten-mittag, B.; Formanek, B.; Dammann, G. Gender differences of symptom reporting and medical health care utilization. Eur. J. Epidemiol. 2000, 516, 11–18. [Google Scholar]
- Haskell, S.G.; Mattocks, K.; Goulet, J.; Krebs, E.; Skanderson, M.; Leslie, D.; Justice, A.C.; Yano, E.M.; Brandt, C. The Burden of Illness in the First Year Home: Do Male and Female VA Users Differ in Health Conditions and Healthcare Utilization. Women’s Health Issues 2011, 21, 92–97. [Google Scholar] [CrossRef] [Green Version]
- Shalev, V.; Chodick, G.; Heymann, A.D.; Kokia, E. Gender differences in healthcare utilization and medical indicators among patients with diabetes. Public Health 2005, 119, 45–49. [Google Scholar] [CrossRef] [PubMed]
- Vlajinac, H.; Adanja, B.; Marinković, J.; Jarebinski, M. Influence of socio-economic and other factors on rheumatic fever occurrence. Eur. J. Epidemiol. 1991, 7, 702–704. [Google Scholar] [CrossRef] [PubMed]
Baseline Characteristic | |
---|---|
Total number of interviewees, n | 6958 (100) |
Age (Years), Median ± IQR | 33 ± 22 |
Gender (Female), n (%) | 4418 (63.5) |
Educational Status, n (%) | |
Uneducated | 1494 (21.5) |
Primary Education | 832 (12.0) |
Preparatory | 259 (3.7) |
Secondary | 1900 (27.3) |
Post-secondary | 2473 (35.5) |
Hospital Location, n (%) | |
Cairo | 2235 (32.1) |
Other Governates | 4723 (67.9) |
Sore Throat Experience, n (%) | |
Personal experience of a sore throat | 5678 (81.7) |
Child experienced sore throat | 4794 (72.7) |
Known a family member with frequent sore throat $ | 3963 (57.2) |
Reported receiving antibiotics for sore throat * | 4767 (73.3) |
Medications prescribed by a medical professional ** | 4487 (69.3) |
Peer-prescriptions ** | 317 (4.9) |
Self-prescriptions ** | 1670 (25.8) |
Univariate Model | Multivariate Model † | ||||||
---|---|---|---|---|---|---|---|
n (% Consulting Physician) | OR | 95% CI | OR | 95% CI | |||
LL | UL | LL | UL | ||||
Age (Years) | |||||||
Reference = First quartile (4 to 23) | 1552 (59.7%) | ||||||
Second quartile (23 to 33) | 1638 (69.4%) | 1.526 | 1.318 | 1.766 | 1.440 | 1.243 | 1.670 |
Third quartile (33 to 45) | 1592 (74.9%) | 2.016 | 1.731 | 2.347 | 1.851 | 1.583 | 2.164 |
Fourth quartile (45 to 93) | 1347 (69.7%) | 1.552 | 1.330 | 1.811 | 1.416 | 1.203 | 1.668 |
Gender | |||||||
Reference = Male | 2292 (66.4%) | ||||||
Female | 4180 (70.9%) | 1.228 | 1.101 | 1.370 | 1.182 | 1.054 | 1.326 |
Educational status | |||||||
Reference = uneducated | 1330 (76.4%) | ||||||
Primary | 770 (69.9%) | 0.717 | 0.587 | 0.875 | 0.792 | 0.642 | 0.977 |
Preparatory | 246 (60.2%) | 0.467 | 0.351 | 0.621 | 0.534 | 0.398 | 0.717 |
Secondary | 1747 (70.5%) | 0.737 | 0.626 | 0.868 | 0.812 | 0.682 | 0.967 |
Post-secondary | 2382 (65.2%) | 0.580 | 0.498 | 0.675 | 0.720 | 0.608 | 0.851 |
Hospital Location | |||||||
Reference = Cairo | 2099 (67.1%) | ||||||
Other Governates | 4376 (70.4%) | 1.165 | 1.042 | 1.303 | 1.251 | 1.107 | 1.413 |
Univariate Model | Multivariate Model † | |||||
---|---|---|---|---|---|---|
MD | 95% CI | MD | 95% CI | |||
LL | UL | LL | UL | |||
Age (Years) †† | ||||||
Reference = First quartile (4 to 23) | ||||||
Second quartile (23 to 33) | 0.670 | 0.475 | 0.865 | 0.682 | 0.490 | 0.875 |
Third quartile (33 to 45) | 1.084 | 0.887 | 1.281 | 1.273 | 1.076 | 1.471 |
Fourth quartile (45 to 93) | 1.169 | 0.965 | 1.373 | 1.576 | 1.366 | 1.787 |
Gender § | ||||||
Reference = Male | ||||||
Female | 0.749 | 0.604 | 0.893 | 0.888 | 0.743 | 1.033 |
Educational status | ||||||
Reference = uneducated | ||||||
Primary | −0.308 | −0.560 | −0.057 | 0.086 | −0.169 | 0.341 |
Preparatory | −0.133 | −0.524 | 0.257 | 0.107 | −0.276 | 0.489 |
Secondary | 0.180 | −0.021 | 0.381 | 0.577 | 0.369 | 0.785 |
Post-secondary | 0.457 | 0.267 | 0.648 | 1.101 | 0.898 | 1.304 |
Hospital Location | ||||||
Reference = Cairo | ||||||
Other Governates | 0.915 | 0.767 | 1.064 | 0.668 | 0.510 | 0.826 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sayed, A.K.; Se’eda, H.; Eltewacy, N.K.; El Sherif, L.; Ghalioub, H.S.; Sayed, A.; Afifi, A.M.; Almoallim, H.S.; Alharbi, S.A.; Abushouk, A.I. Awareness of Rheumatic Heart Disease in Egypt: A National Multicenter Study. J. Cardiovasc. Dev. Dis. 2021, 8, 108. https://doi.org/10.3390/jcdd8090108
Sayed AK, Se’eda H, Eltewacy NK, El Sherif L, Ghalioub HS, Sayed A, Afifi AM, Almoallim HS, Alharbi SA, Abushouk AI. Awareness of Rheumatic Heart Disease in Egypt: A National Multicenter Study. Journal of Cardiovascular Development and Disease. 2021; 8(9):108. https://doi.org/10.3390/jcdd8090108
Chicago/Turabian StyleSayed, Ahmed Kamal, Hussien Se’eda, Nael Kamel Eltewacy, Loalo’a El Sherif, Hagar Samy Ghalioub, Ahmed Sayed, Ahmed M. Afifi, Hesham S. Almoallim, Sulaiman Ali Alharbi, and Abdelrahman I. Abushouk. 2021. "Awareness of Rheumatic Heart Disease in Egypt: A National Multicenter Study" Journal of Cardiovascular Development and Disease 8, no. 9: 108. https://doi.org/10.3390/jcdd8090108
APA StyleSayed, A. K., Se’eda, H., Eltewacy, N. K., El Sherif, L., Ghalioub, H. S., Sayed, A., Afifi, A. M., Almoallim, H. S., Alharbi, S. A., & Abushouk, A. I. (2021). Awareness of Rheumatic Heart Disease in Egypt: A National Multicenter Study. Journal of Cardiovascular Development and Disease, 8(9), 108. https://doi.org/10.3390/jcdd8090108